Market Access News | pharmaphorum

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

US blood pressure drug price doubles following shortages

Prices of the generic blood pressure drug valsartan rose more than any other in the US following a recall of much of the drug’s supply, according to press reports.

News

Samsung Bioepis' Humira biosimilar launches in EU

Samsung Bioepis has become the latest biosimilars company to confirm it has launched a cheaper near-copy of AbbVie’s Humira inflammatory diseases blockbuster, after its European patent expi

News

Billions up for grabs as EU patent on AbbVie's Humira expire...

The patent for Humira, the world’s bestselling drug, expires in Europe today – opening the door for a host of cheaper biosimilars to hit the market.

News

Sandoz free to launch Humira biosimilar following AbbVie dea...

Novartis’ generics and biosimilars arm, Sandoz, has confirmed it is to launch its biosimilar of AbbVie’s Humira (adalimumab) in Europe this year after the two companies settled intellectual

News

Celltrion's Rituxan biosimilar gets glowing review ahead of ...

Reviewers from the FDA have given Celltrion’s biosimilar of Roche’s blood cancer blockbuster Rituxan a glowing report ahead of a key meeting of its advisers tomorrow.

News